191 related articles for article (PubMed ID: 36356998)
61. Epidemiology, management and the associated burden of mental health illness, atopic and autoimmune conditions, and common infections in alopecia areata: protocol for an observational study series.
Harries M; Macbeth AE; Holmes S; Thompson AR; Chiu WS; Gallardo WR; Messenger AG; Tziotzios C; de Lusignan S
BMJ Open; 2021 Nov; 11(11):e045718. PubMed ID: 34785540
[TBL] [Abstract][Full Text] [Related]
62. Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
Cheetham NJ; Kibble M; Wong A; Silverwood RJ; Knuppel A; Williams DM; Hamilton OKL; Lee PH; Bridger Staatz C; Di Gessa G; Zhu J; Katikireddi SV; Ploubidis GB; Thompson EJ; Bowyer RCE; Zhang X; Abbasian G; Garcia MP; Hart D; Seow J; Graham C; Kouphou N; Acors S; Malim MH; Mitchell RE; Northstone K; Major-Smith D; Matthews S; Breeze T; Crawford M; Molloy L; Kwong ASF; Doores K; Chaturvedi N; Duncan EL; Timpson NJ; Steves CJ
Elife; 2023 Jan; 12():. PubMed ID: 36692910
[TBL] [Abstract][Full Text] [Related]
63. COVID-19 vaccine effectiveness among people living with and without HIV in South Carolina, USA: protocol of a population-based cohort study.
Xueying Y; Zhang J; Olatosi B; Weissman S; Li X
BMJ Open; 2022 Aug; 12(8):e067095. PubMed ID: 35998950
[TBL] [Abstract][Full Text] [Related]
64. SARS-CoV-2 infection risk among 77,587 healthcare workers: a national observational longitudinal cohort study in Wales, United Kingdom, April to November 2020.
Hollinghurst J; North L; Szakmany T; Pugh R; Davies GA; Sivakumaran S; Jarvis R; Rolles M; Pickrell WO; Akbari A; Davies G; Griffiths R; Lyons J; Torabi F; Fry R; Gravenor MB; Lyons RA
J R Soc Med; 2022 Dec; 115(12):467-478. PubMed ID: 35796183
[TBL] [Abstract][Full Text] [Related]
65. Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.
Eyre DW; Futschik M; Tunkel S; Wei J; Cole-Hamilton J; Saquib R; Germanacos N; Dodgson AR; Klapper PE; Sudhanva M; Kenny C; Marks P; Blandford E; Hopkins S; Peto TEA; Fowler T
Lancet Infect Dis; 2023 Aug; 23(8):922-932. PubMed ID: 37001541
[TBL] [Abstract][Full Text] [Related]
66. Study protocol for monitoring SARS-CoV-2 infection and its determinants in Catalonia (Spain): an observational and participatory research approach in a Sentinel Network of Schools.
Bordas A; Soriano-Arandes A; Subirana M; Malagrida R; Reyes-Urueña JM; Folch C; Soler-Palacin P; Gascón M; Sunyer J; Anton A; Blanco I; Fernández-Morales J; Colom-Cadena A; Sentís A; Pumarola T; Basora J; Casabona J;
BMJ Open; 2022 Jan; 12(1):e055649. PubMed ID: 35078847
[TBL] [Abstract][Full Text] [Related]
67. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
68. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
[TBL] [Abstract][Full Text] [Related]
69. Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data.
McQuaid F; Mulholland R; Sangpang Rai Y; Agrawal U; Bedford H; Cameron JC; Gibbons C; Roy P; Sheikh A; Shi T; Simpson CR; Tait J; Tessier E; Turner S; Villacampa Ortega J; White J; Wood R
PLoS Med; 2022 Feb; 19(2):e1003916. PubMed ID: 35192611
[TBL] [Abstract][Full Text] [Related]
70. Effect of SARS-CoV-2 infection in neonates or in pregnancy on developmental outcomes at 21-24 months (SINEPOST): study protocol for a prospective cohort study.
Woodward K; Cornish RP; Gale C; Johnson S; Knight M; Kurinczuk J; Chakkarapani E
BMJ Paediatr Open; 2022 Sep; 6(1):. PubMed ID: 36645759
[TBL] [Abstract][Full Text] [Related]
71. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
72. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study.
Cloete J; Kruger A; Masha M; du Plessis NM; Mawela D; Tshukudu M; Manyane T; Komane L; Venter M; Jassat W; Goga A; Feucht U
Lancet Child Adolesc Health; 2022 May; 6(5):294-302. PubMed ID: 35189083
[TBL] [Abstract][Full Text] [Related]
73. Common protocol for validation of the QCOVID algorithm across the four UK nations.
Kerr S; Robertson C; Nafilyan V; Lyons RA; Kee F; Cardwell CR; Coupland C; Lyons J; Humberstone B; Hippisley-Cox J; Sheikh A
BMJ Open; 2022 Jun; 12(6):e050994. PubMed ID: 35701053
[TBL] [Abstract][Full Text] [Related]
74. Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: protocol for an observational cohort study (LongCOVID-study).
Mutubuki EN; van der Maaden T; Leung KY; Wong A; Tulen AD; de Bruijn S; Haverman L; Knoop H; Franz E; van Hoek AJ; van den Wijngaard CC
BMJ Open; 2022 Jul; 12(7):e062439. PubMed ID: 35777877
[TBL] [Abstract][Full Text] [Related]
75. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies.
Behnood SA; Shafran R; Bennett SD; Zhang AXD; O'Mahoney LL; Stephenson TJ; Ladhani SN; De Stavola BL; Viner RM; Swann OV
J Infect; 2022 Feb; 84(2):158-170. PubMed ID: 34813820
[TBL] [Abstract][Full Text] [Related]
76. COVID-19 mitigation measures in primary schools and association with infection and school staff wellbeing: An observational survey linked with routine data in Wales, UK.
Marchant E; Griffiths L; Crick T; Fry R; Hollinghurst J; James M; Cowley L; Abbasizanjani H; Torabi F; Thompson DA; Kennedy J; Akbari A; Gravenor MB; Lyons RA; Brophy S
PLoS One; 2022; 17(2):e0264023. PubMed ID: 35226680
[TBL] [Abstract][Full Text] [Related]
77. REducing unwarranted variation in the Delivery of high qUality hip fraCture services in England and Wales (REDUCE): protocol for a mixed-methods study.
Patel R; Drew S; Johansen A; Chesser T; Javaid MK; Griffin XL; Jones T; Griffin J; Bradshaw M; Whale K; Barbosa EC; Marques EMR; Ben-Shlomo Y; Gooberman-Hill R; Judge A; Gregson CL
BMJ Open; 2021 May; 11(5):e049763. PubMed ID: 34011603
[TBL] [Abstract][Full Text] [Related]
78. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.
Bager P; Wohlfahrt J; Fonager J; Rasmussen M; Albertsen M; Michaelsen TY; Møller CH; Ethelberg S; Legarth R; Button MSF; Gubbels S; Voldstedlund M; Mølbak K; Skov RL; Fomsgaard A; Krause TG;
Lancet Infect Dis; 2021 Nov; 21(11):1507-1517. PubMed ID: 34171231
[TBL] [Abstract][Full Text] [Related]
79. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Duvignaud A; Lhomme E; Pistone T; Onaisi R; Sitta R; Journot V; Nguyen D; Peiffer-Smadja N; Crémer A; Bouchet S; Darnaud T; Poitrenaud D; Piroth L; Binquet C; Michel JF; Lefèvre B; Lebeaux D; Lebel J; Dupouy J; Roussillon C; Gimbert A; Wittkop L; Thiébaut R; Orne-Gliemann J; Joseph JP; Richert L; Anglaret X; Malvy D;
Trials; 2020 Oct; 21(1):846. PubMed ID: 33050924
[TBL] [Abstract][Full Text] [Related]
80. The seroprevalence of SARS-CoV-2 in a rural southwest community.
Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
